(Q46853190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

A surveillance study of escitalopram treatment of depressed patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Ivan Tuma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Helena Rösslerova

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Antidepressant-associated mania with escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

Escitalopram prevents relapse of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.1.1

21 January 2018

Identifiers

DOI

10.1517/14656566.9.1.1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076333%20AND%20SRC:MED&resulttype=core&format=json

release_aekot35rjzglhkivfshkkn4zfm

29 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aekot35rjzglhkivfshkkn4zfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference